{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:06Z","timestamp":1755216786201,"version":"3.43.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pediatric B-lymphoblastic lymphoma is an uncommon subtype of non-Hodgkin lymphoma. Studies regarding the biology, clinical course, and approach to relapse are limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Observations:<\/jats:title>\n            <jats:p>We present a series of children with B-lymphoblastic lymphoma to describe the clinical course at diagnosis and relapse as well as the role of tumor cytogenetics, immunotherapy, and hematopoietic stem cell transplant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The prognostic significance of cytogenetic changes in B-lymphoblastic lymphoma is not well described but may offer improved risk stratification. Immunotherapy may offer salvage options for relapsed disease and can serve as a bridge to transplant.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002828","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T14:00:45Z","timestamp":1708956045000},"page":"e254-e258","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["B-Lymphoblastic Lymphoma in Children: A Case Series From a Single Institution"],"prefix":"10.1097","volume":"46","author":[{"given":"Kaitlin J.","family":"Devine","sequence":"first","affiliation":[{"name":"Division of Oncology, The Children\u2019s Hospital of Philadelphia"},{"name":"Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirva","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Division of Oncology, The Children\u2019s Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne F.","family":"Reilly","sequence":"additional","affiliation":[{"name":"Division of Oncology, The Children\u2019s Hospital of Philadelphia"},{"name":"Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br J Haematol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"e26363","DOI":"10.1002\/pbc.26363","article-title":"Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues","volume":"64","author":"Meyer","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pbc.24149","article-title":"Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children\u2019s Oncology Group trial A5971: a report from the Children\u2019s Oncology Group","volume":"59","author":"Termuhlen","year":"2012","journal-title":"Pediatr Blood Cance"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjh.12460","article-title":"Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children\u2019s Oncology Group","volume":"162","author":"Termuhlen","year":"2013","journal-title":"Br J Haematol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/cancers13092075","article-title":"Treatment and outcome analysis of 639 relapsed non-Hodgkin lymphomas in children and adolescents and resulting treatment recommendations","volume":"13","author":"Burkhardt","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/jcm10091926","article-title":"Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia","volume":"10","author":"Inaba","year":"2021","journal-title":"J Clin Med"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1080\/10428194.2020.1761970","article-title":"Analysis of clinicopathological and cytogenetic differences between B-lymphoblastic lymphoma and B-lymphoblastic leukemia in childhood","volume":"61","author":"Knez","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11899-021-00648-y","article-title":"Acute lymphoblastic leukemia and acute lymphoblastic lymphoma: same disease spectrum but two distinct diagnoses","volume":"16","author":"Kline","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cancergencyto.2009.01.002","article-title":"High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage","volume":"191","author":"Schraders","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/leu.2009.42","article-title":"Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)\/TCF3-PBX1","volume":"23","author":"Jeha","year":"2009","journal-title":"Leukemia"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3109\/08880018.2014.935837","article-title":"Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia","volume":"31","author":"ElGendi","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3324\/haematol.2018.199885","article-title":"B-lymphoblastic lymphoma with TCF3-PBX1 fusion gene","volume":"104","author":"Kubota-Tanaka","year":"2019","journal-title":"Haematologica"},{"key":"R17-20250804","first-page":"e1559","article-title":"Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1","volume":"5","author":"Shirai","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3324\/haematol.2018.210104","article-title":"Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation","volume":"104","author":"Mouttet","year":"2019","journal-title":"Haematologica"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10555-019-09834-0","article-title":"Immunotherapy in pediatric acute lymphoblastic leukemia","volume":"38","author":"Inaba","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"e28718","DOI":"10.1002\/pbc.28718","article-title":"Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia","volume":"68","author":"Contreras","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/S2352-3026(21)00238-6","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials [published correction appears in Lancet Haematol. 2021 Nov;8(11):e789]","volume":"8","author":"Leahy","year":"2021","journal-title":"Lancet Haematol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41375-022-01546-9","article-title":"CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study","volume":"36","author":"Jacoby","year":"2022","journal-title":"Leukemia"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:02:28Z","timestamp":1754337748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002828","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"2023-10-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}